Results 201 to 210 of about 3,233,933 (403)

Central nervous system progression and liquid biopsy in patients with oncogene addicted non-small cell lung cancer treated with ALK/ROS1 inhibitors

, 2020
Mihaela Aldea, Damien Vasseur, Cristina Teixidó, Laura Mezquita   +3 more
openalex   +1 more source

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein, Haoqi Sun, Sophie Lehnerer, Lea Gerischer, Maximilian Mönch, Christian Meisel, Andreas Meisel, Pushpa Narayanaswami   +7 more
wiley   +1 more source

Estrogen synthesized in the central nervous system enhances MC 4 R expression and reduces food intake [PDF]

Takanori Hayashi, Kanako Kumamoto, Tatsuya Kobayashi, Xinfeng Hou, Shizuko Nagao, Nobuhiro Harada, Shin‐ichiro Honda, Yohei Shimono, Eiji Nishio   +8 more
openalex   +1 more source

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

Neuro-Oncology, 2017
Q. Ostrom, H. Gittleman, Peter Liao, Toni Vecchione-Koval, Yingli Wolinsky, C. Kruchko, J. Barnholtz-Sloan   +6 more
semanticscholar   +1 more source

Drug delivery to the central nervous system

Nature Reviews Materials, 2021
Elizabeth A. Nance, S. Pun, R. Saigal, D. Sellers   +3 more
semanticscholar   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang, Jianli Zhao, Xue Zhao, Xiaowei Hu, Zichun Xiao, Jie Wu, Xiaowen Li, Jing Xu, Yu‐Jing Li   +8 more
wiley   +1 more source

Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) on Pharmacokinetics and Central Nervous System Penetration of Abacavir and Zidovudine in the Mouse

, 2008
Nagdeep Giri, Naveed Shaik, Guoyu Pan, Tetsuya Terasaki, Chisato Mukai, Shinji Kitagaki, Naoki Miyakoshi, William F. Elmquist   +7 more
openalex   +2 more sources

Chemical mediators in the central nervous system [PDF]

, 1968
Pulak Lahiri, Paromita Sen
openalex   +1 more source

Astrocyte scar formation aids central nervous system axon regeneration

Nature, 2016
Mark A. Anderson, J. Burda, Yilong Ren, Y. Ao, T.M. O’Shea, R. Kawaguchi, G. Coppola, B. Khakh, T. Deming, M. Sofroniew   +9 more
semanticscholar   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz, Josefine Eck, Joel S. Winston, Kate Baker   +3 more
wiley   +1 more source